New Tool Offers Hope for Curing HIV by Revealing Secrets of Infected Cells

For people living with human immunodeficiency virus (HIV), antiretroviral therapy (ART) is life-saving, preventing illness and transmission by suppressing viral replication. However, even with ART, fragments of the virus persist in the body, contributing to inflammation and increasing the risk of long-term health problems. Now, a new tool called HIV-seq is offering scientists a deeper understanding of these persistent viral reservoirs, potentially paving the way for a cure.

The Challenge of the HIV Reservoir

Historically, HIV-infected cells were considered to be in a “latent” state – completely inactive. However, research now shows that some reservoir cells remain active, continuing to produce viral products even while on ART. These active cells contribute to chronic inflammation, which can lead to organ damage and an increased risk of cardiovascular issues [1]. The number of these active reservoir cells also influences how quickly HIV rebounds if treatment is interrupted.

Introducing HIV-seq: A Novel Tool for Analysis

Scientists at Gladstone Institutes and the San Francisco Veterans Affairs Medical Center have developed HIV-seq, a new tool for profiling the characteristics of rare HIV-infected cells. This tool addresses limitations in existing methods, such as single-cell RNA sequencing, which often struggle to detect enough reservoir cells for meaningful analysis.

Traditional single-cell RNA sequencing methods often miss active reservoir cells because they require specific RNA fragments that HIV-produced RNA doesn’t always match. HIV-seq is specifically designed to recognize cells producing HIV RNA fragments, allowing for more accurate and comprehensive analysis.

What HIV-seq Reveals About Reservoir Cells

Using HIV-seq, researchers have identified key differences in HIV-infected cells before and after starting ART. The tool recovered and analyzed more HIV-infected cells, and higher numbers of HIV RNA within those infected cells, than previous methods .

Here’s what they found:

• Cells Before Therapy: These cells exhibited “fiery” characteristics, meaning they had proteins associated with killing other cells and lower levels of genes linked to HIV suppression.
• Cells After Therapy: Reservoir cells in people on ART were “quieter,” with anti-inflammatory features and an increased ability to evade death and survive long-term. They also showed higher levels of genes that promote cell survival.

The research also uncovered higher levels of proteins associated with long-term cell multiplication and suppression of both HIV production and the immune system in cells from people on therapy. These discoveries could explain how active reservoir cells remain undetected by the immune system for so long.

Implications for Future Treatments

The insights gained from HIV-seq are already informing ongoing research. For example, the findings support a clinical trial testing a drug that targets a pathway HIV uses to promote host cell survival . Researchers are now testing whether they can prevent HIV reservoir cells from multiplying by targeting these pro-survival pathways.

“We’re already building on some of our new findings by testing, in various laboratory models, whether we can stop HIV reservoir cells from multiplying by targeting these pro-survival pathways,” said Nadia Roan, PhD, senior investigator at Gladstone Institutes .

Understanding Latent HIV Reservoirs

Current antiretroviral therapy can suppress active HIV replication, but it cannot eliminate cells that are latently infected with HIV [1]. These latently infected cells form reservoirs that can seed viral rebound if ART is interrupted . Recent research suggests that the establishment of these reservoirs is influenced by immune-mediated selection, leading to the persistence of genetically intact proviruses that are best able to avoid clearance .

The persistence of the latent HIV reservoir remains a major challenge in curing HIV infection .

Published March 3, 2026 in Nature Communications, this research offers a significant step forward in understanding and ultimately overcoming this challenge.